SEC filing details

Form

Filing Date

08.01.2024

Document Date

08.01.2024

Form Description

Report of unscheduled material events or corporate event

Filing Group

Current Reports

Company

BridgeBio Pharma

Issuer

BRIDGEBIO PHARMA, INC.

iXBRL

View HTML

XBRL Viewer

Print Page

Email Alerts

RSS Feeds

Contact IR

join our investor mailing list

Stay informed on everything that is happening at BridgeBio Investor Relations.

Required fields denoted by an asterisk ().

3160 Porter Drive, Suite 250, Palo Alto, CA, 94304 | 650-391-9740 | info@bridgebio.com | MAT-AS—0001